Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06813365
What this trial is testing

Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)

Who this might be right for
Nonsmall-cell Lung Cancer
Dizal Pharmaceuticals 300
Not applicableUnknownNCT03938012
What this trial is testing

Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the LungSquamous Cell Carcinoma of the Head and Neck
National University Hospital, Singapore 80
Large-scale testing (Phase 3)UnknownNCT02875457
What this trial is testing

Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 100
Large-scale testing (Phase 3)Looking for participantsNCT07182682
What this trial is testing

Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery

Who this might be right for
Non-Small Cell Lung Cancer
Dizal (Jiangsu) Pharmaceutical Co., Ltd. 360
Not applicableEnrolling By InvitationNCT06752395
What this trial is testing

Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions

Who this might be right for
Lung Cancer (NSCLC)
Pusan National University Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05211895
What this trial is testing

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 791
Early research (Phase 1)Study completedNCT02858869
What this trial is testing

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more
Emory University 25
Large-scale testing (Phase 3)Study completedNCT03743051
What this trial is testing

Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Cachexia; CancerNon Small Cell Lung Cancer
Helsinn Healthcare SA 318
Testing effectiveness (Phase 2)UnknownNCT04890795
What this trial is testing

A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Advenchen Laboratories Nanjing Ltd. 237
Not applicableActive Not RecruitingNCT06008353
What this trial is testing

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

Who this might be right for
Extensive-stage Small-cell Lung Cancer
AstraZeneca 60
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Not applicableStudy completedNCT00717002
What this trial is testing

Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study

Who this might be right for
Non Small Cell Lung Cancer
National University Hospital, Singapore
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT04803305
What this trial is testing

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Who this might be right for
Non-small Cell Lung CancerPancreatic CancerColorectal Cancer+7 more
Pfizer 18
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Early research (Phase 1)Study completedNCT03735628
What this trial is testing

Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Hepatocellular Carcinoma (HCC)
Bayer 16
Testing effectiveness (Phase 2)Study completedNCT01750281
What this trial is testing

Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 212
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851169
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 58
Testing effectiveness (Phase 2)Looking for participantsNCT05924841
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 100
Next Page